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in all hearts from the onset of the PC/control period (n = 6 per group)
and terminated 2.5 min prior to CO. Coronary flow and LV pressure were
monitored throughout each protocol, and area of necrosis (AN)was assessed
by tetrazolium staining and expressed as a % of the area at risk of infarction
(AR).
ANIAR
Protocol1: Control 63 l 2%
Pc 30+ 6%**
Protocol2: Control+’Neomycin 56+ 10%
PC+ Neomycin 54* 9%
Protocol 1 confirmed the expected reduction in infarct size in PC hearts
versus controls (** p < 0.01). In contrast, in Protocol 2, infarct size was com-
parable in both control and PC hearts treated with neomycin. Impotiantly,
protection with PC - and loss of protection with neomycin - was not due to
differences in coronary flow or LV pressure among groups (data not shown).
These results support the concept that activation of the second messenger
inositol (1,4,5)-trisphosphate (and subsequent release of calcium from intra-
cellular stores) during brief antecedent ischemisJreperfusionis an important
mediator of infarct size reduction with preconditioning in this isolated rabbit
heart model.
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infsrotion: Interaction between age and right
ventricular infarction
H. Bueno, R. Lopez-Palop, J. Osende, J. Garcfa-Garcia, E. Perez-David,
J.A. Serrano, J.L. Lopez-SendOn,J.L. Delcan. Hospital General Gregorio
Marafin6n, Madrid, Spain
Itis known that patients with acute inferior myocerdial infarction (lMl) and
right ventricular infarction (RVI) have a worse prognosis than those without it
and that the elderly also have a poorer outcome. To assess the influence of
age on prognosis of IMI and its relation with RVI, we studied the in-hospital
clinical outcome of 652 consecutive patients admitted to our CCU with a
definite diagnosis of IMI of less of 46 hours of evolution and compared their
outcomes according to their age and to the presence of RVI.
Resu/ts.’Themean ageofthewhole groupwa.s73+ 13years, 80% males.
Thrombolysis was used in 47% of patients and primary PTCA in 3%. The
incidence of RVI was 35%. The total in-hospital mortality rate was 12% (20Y0
inpatients with RVI, 5% in those without, p < 0.001). A significant (p < 0.001)
mrrelation between age and mortality was found in both groups. The addition
of the interaction factor RV1-ageto the logistic regression model was only
significant in patients older than 65 year. We plotted age and mortality (Fig.)
and found an exponential increase in mortality which was only significant in
patients older than 65 years with RVI (logistic regression coefficient D:0.152,
p <0.0005. In patients without RVI, ~: 0.021, p < 0.55).
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Conclusion: The in-hospital mortality of IMI is age-dependent, but this
dependence is essentially related to the precence of RVI.
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El7772 Non-Q wave myocardial infarction ia notindapandently associated with worsa outcome in the
aldarly
J.E. Murillo, J. Chen, 0. Jagasia, Y. Wang, H.M. Krumholz. YaleUrriversity
School ofhfedicirre, NewHaven, CT USA
Several studies, predominately of younger patient.s,suggeat that non-Q wave
myocardial infarction (NQWMI) has a better in-hospital outcome than Q-
wave myccerdial infarction (QWMI), but the advantage is lost over time.
To determine the association of NQWMI with outcome in the elderly, we
used the Connecticut cohort of the Cooperative Cardiovascular Project pilot
datebase which contains medical record information for Medicare patients
admitted with acute myocardial infarction (Ml). Both admission and discharge
electrocardiograms were interpreted to classify patients by the presence of
Q waves,
Among the 2,720 patients >65 years with interpretable electrocardio-
grams, 1,533 patients (56%) had an NQWMI. Patients with NQWMI had a
significantly lower in-hoepital mortality rate than QWMI (12% vs. 19%, P <
0.001). Among the 2,309 patients who survived the hospitalization, 1,350
(58%) had a NQWMI. These patients were significantly older and more likely
to have a history of Ml, CHF, diabetes, afid revascularization surgety. The
rate of cath during the initial hospitalization was 36% for the two groups. Dur-
ing the year after discharge, NQWMI patients had a mortality rate that was
not significantly different from QWMI patients (20% vs. 17%, respectively,
P = 0.12). After adjusting for demographic, clinical, pharmacological, and
electrocardiographic variables, and treatment, NQWMI was not associated
with any increased risk mmpared with QWMI (OR 0.89, 95% Cl 0.68 to
1,15, P value 0.37). The rate of readmission for any cause during the year
postdischarge was also not different for both groups: 50.6% for QWMI and
50.3% for NQWMI.
Conclusion: Among elderly hospital survivors of AMI, NQWMI does not
predict higher one-year mortality or one-year readmission when compared
to QWMI.
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~[ RagiOnalvariatiOn inmYOcardialinfarc~iOn care:~he
cooperative cardiovascular project experience
T,A. Marciniak, H.M. Krumholz. Health Care FirrarrcingAdrrrirristration,
Baltimore, MD, and Ya/aUrriversifySchool of Medicine, New Haven, CT
USA
The Health Care Financing Administration’s Cooperative Cardiovascular
Project abstracted 224,377 medical records of hospital discharges of Medi-
care patients with acute myocardial infarction (AMI) from February, 1994,
through July, 1995. These data show significant variations in care processes
and outcomes acrossthe nation when the data are analyzed by the nine Cen-
sus Bureau regions. The most striking variations are lower use of invasive
procedures in the New England region (angiography 22Y0,angioplasty 8Y.,
CABG 6%) and greater use of beta blockers at discharge (55%) compared
to the national means (angiography 36%, angioplasty 14’%.,CABG 9%, beta
blockars 39%). The variations in rates for other process measures are smaller
and more randomly distributed: reperfusion in ideal candidates (mean 66%,
range 59 to 74%); aspirin during the stay (mean 79%, range 77 to 82%) and
at discharge (mean 67%, range 65 to 71Yo); and ACE inhibitor use (mean
56%, range 52 to 64%) and calcium channel blocker avoidance (mean 64%,
range 81 to 87Yo)at discharge in patients with reduced LVEF. The 30-day
mortality rate is lowest in the New England region (15.3%), compared to the
national mean of 17.8%,and the survival advantage in New England persists
after risk adjustment (relative risk 0.8). Conclusion: Regional variations in
AMI care persist despite the availability of good national guidelines for AMI
treatment.
9:15
-I Decisio.ma~i.gi. octogenarian~,~haracteristics
associated with selection for catheterization
following acute myocardial infarction
P.J. Higgins, D.E. Wennberg, T.J. Ryan, Jr.,C.T. Lambrew, W.J. French for
the Participants in the National Registry of Myocardial Infarction. Maine
Medical Center, Portland, MEand Hatior-UCLA, Torrance, CA, USA
Following acute Ml, pts ?80 yrs undergo cardiac catheterization (cath) less
frequently than younger pts yet have a higher overall mortality. To under-
stand post Ml decision making and resource utilization in octogenarians we
analyzed 21,354 pts ?80 yrs from the NRMI-2 regist!y admitted with Ml to
hospitals with cath facilities in the US from 11/94-1/96. Univariate and mul-
tivariate logistic regression analyses were used to assess for independent
associations with post Ml cath.
Multivariataoddsratiosfor postMl cath
Positive OR (950/0Cl) Negative OR (95”/0Cl)
PriorPTCA 1.9 (1.7, 2.3) PriorMl 0.9 (0.8, 0.99)
PriorCABG 1.3 (1.2. 1.5) PriorCHF 0.6 (0,5, 0,7)
Male Gender 1.3 ~1.2; 1.4j PriorCVA 0.6 (0.5; o.7j
RecurrentAngina 2.1 (1,9, 2.4) Shock 0.S (0.6, 0.9)
RecurrentMl 1,2 (1.01, 1.5) Hypotension 0.8 (0.7, 0,9)
ThrombelyticRx 1.3 (1.2, 1.5) CHF 0.9 (0,8, 0,99)
SBP ? 90 mmHg 1.7 (1,3, 2,2) New England 0.5 (0.4, 0.7)
